期刊文献+

国产喹硫平治疗老年痴呆精神行为症状的开放性研究 被引量:1

原文传递
导出
摘要 我们对国产喹硫平治疗老年痴呆的精神行为症状(BPSD)疗效及安全性进行开放性临床研究,报道如下。 对象为本2005年10月至2006年10月在本科住院的30例患者。入组标准:符合中国精神障碍分类与诊断标准第3版的阿尔茨海默病或血管性痴呆的诊断标准;简易智能状态检查〈24分;伴幻觉妄想、情感障碍、行为障碍等精神病性症状。排除其他精神疾病共病或伴有严蘑躯体疾病。入组前征得对患者有监护权家属的知情同意。30例中男19例,女11例;平均年龄(72±7)岁;病程(16±3)个月。
出处 《中华精神科杂志》 CAS CSCD 北大核心 2007年第4期200-200,共1页 Chinese Journal of Psychiatry
  • 相关文献

参考文献2

  • 1Deberdt WG, Dysken MW, Rappaport SA, et al. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Am J Geriatr Psychiatry, 2005, 13:722-730.
  • 2冯少慧,王锐,曾林,张惠实.奎硫平治疗老年痴呆患者精神行为症状研究[J].临床精神医学杂志,2005,15(3):177-177. 被引量:29

二级参考文献5

  • 1孙新宇,高之旭,冯锋,温全球,冯少慧,盛建华,陈建,苗国栋,于欣.氟哌啶醇与利培酮治疗痴呆患者精神行为症状的随机双盲对照研究[J].中华精神科杂志,2004,37(3):156-159. 被引量:54
  • 2Devanand DP,Jacobs DM, Tang MX,et al. The course of psychopathologic features in mild to moderate Alzheimer disease[ J ]. Arch Gen Psychiatry, 1997,54 : 257-263.
  • 3Reisberg B, Borertstein J, Salob SP, et al. Behavioral symptoms in Alzheimer' s disease: phenomenology and treatment [ J ]. J Clin Psychiatry, 1987,48:9-15.
  • 4Fujikawa T, Takahashi T, Kinoshita A, et al. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type[J]. Neuropsychobiology,2004,49:201-204.
  • 5范洪玉,王桂英,黄劲松.奎硫平治疗老年期精神障碍32例临床观察[J].临床精神医学杂志,2004,14(3):166-166. 被引量:28

共引文献28

同被引文献17

  • 1Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review[J].J Clin Neurol, 2011, 7(1): 1-9.doi: 1O.3988/jcn.2011.7.1.1.
  • 2Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study[J].Stroke, 2010, 41(10 Suppl): SI03-SI06.doi: 10.11611STROKEAHA.llO.595181.
  • 3Auriel E, Greenberg SM. The pathophysiology and clinical presentation of cerebral amyloid angiopatby[J].Curr Atheroscler Rep, 2012, 14(4):343-350.doi: 10.10071 sI1883-012-0254-z.
  • 4Yamada M. Brain hemorrhages in cerebral amyloid angiopathy[J].Semin Thromb Hemost, 2013. 39(8):955-962. doi: 1O.1055/s-0033-1357489.
  • 5Keage HA, Carare RO, Friedland RP, et al. Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review[J].BMC Neural, 2009, 9:3.doi: 10.118611471-2377-9-3.
  • 6Viswanathan A, Greenberg SM. Cerebral amyloid angiopathy in the elderly[J].Ann Neurol, 2011, 70(6):871-880.doi: 10. 1002/ana.225 I 6.
  • 7Arvanitakis Z, Leurgans SE, Wang Z, et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons[J].Ann Neurol, 2011, 69(2):320-327.doi: 10. 10021 ana.22112.
  • 8Knudsen KA, Rosand J, Karluk D, et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria[J].Neurology, 2001, 56(4):537-539.
  • 9Cheng AL, Batool S, McCreary CR, et al. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for deteeting microbleeds[J].Stroke, 2013, 44(1O):2782-2786.doi: 10.11611 STROKEAHA.I13.002267.
  • 10Ghostine S, Raghavan R, Khanlou N, et al. Cerebral amyloid angiopathy: micro-haemorrhages demonstrated by magnetic resonance susceptibility-weighted imaging[J]. Neuropatbol Appl Neurobiol, 2009, 35(1): 116-119.doi: 10.llll/j.1365-2990.2008.00976.x.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部